7th Annual Digital Immuno-Oncology Innovation Forum: Cancer Vaccines, Neo Antigens & Related Modalities Panel
Investing in Biologics Panel
May 19, 2021
- Jeffrey Bockman, PhD, EVP, Head of Oncology Practice, Cello Health BioConsulting
- Andrew Allen, Co-Founder, President & CEO, Gritstone Oncology, Inc.
- Carlos de Sousa, CEO, Ultimovacs ASA
- Frederic Ors, CEO, IMV Inc.
- Mike Mulqueen, VP of Business Development, eTheRNA immunotherapies NV
- Nicolas Poirier, Chief Scientic Ocer, OSE Immunotherapeutics